110 related articles for article (PubMed ID: 2173147)
1. Molecular analysis of two group B streptococcal virulence factors.
Rubens CE; Wessels MR; Kuypers JM; Kasper DL; Weiser JN
Semin Perinatol; 1990 Aug; 14(4 Suppl 1):22-9. PubMed ID: 2173147
[TBL] [Abstract][Full Text] [Related]
2. The putative glycosyltransferase-encoding gene cylJ and the group B Streptococcus (GBS)-specific gene cylK modulate hemolysin production and virulence of GBS.
Forquin MP; Tazi A; Rosa-Fraile M; Poyart C; Trieu-Cuot P; Dramsi S
Infect Immun; 2007 Apr; 75(4):2063-6. PubMed ID: 17283108
[TBL] [Abstract][Full Text] [Related]
3. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.
Wessels MR; Haft RF; Heggen LM; Rubens CE
Infect Immun; 1992 Feb; 60(2):392-400. PubMed ID: 1309720
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.
DeShazer D; Waag DM; Fritz DL; Woods DE
Microb Pathog; 2001 May; 30(5):253-69. PubMed ID: 11373120
[TBL] [Abstract][Full Text] [Related]
5. Role of capsule in pulmonary hypertension induced by group B streptococcus.
Philips JB; Li JX; Gray BM; Pritchard DG; Oliver JR
Pediatr Res; 1992 Apr; 31(4 Pt 1):386-90. PubMed ID: 1315021
[TBL] [Abstract][Full Text] [Related]
6. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.
Rubens CE; Wessels MR; Heggen LM; Kasper DL
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7208-12. PubMed ID: 2823254
[TBL] [Abstract][Full Text] [Related]
7. Bacterial genetics and human immunity to group B streptococci.
Adderson EE; Takahashi S; Bohnsack JF
Mol Genet Metab; 2000; 71(1-2):451-4. PubMed ID: 11001839
[TBL] [Abstract][Full Text] [Related]
8. Lactic acid is a potential virulence factor for group B Streptococcus.
Kling DE; Cavicchio AJ; Sollinger CA; Madoff LC; Schnitzer JJ; Kinane TB
Microb Pathog; 2009 Jan; 46(1):43-52. PubMed ID: 19010409
[TBL] [Abstract][Full Text] [Related]
9. Beta-hemolysin-independent induction of apoptosis of macrophages infected with serotype III group B streptococcus.
Ulett GC; Bohnsack JF; Armstrong J; Adderson EE
J Infect Dis; 2003 Oct; 188(7):1049-53. PubMed ID: 14513426
[TBL] [Abstract][Full Text] [Related]
10. Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis.
Weiser JN; Rubens CE
Infect Immun; 1987 Sep; 55(9):2314-6. PubMed ID: 3040595
[TBL] [Abstract][Full Text] [Related]
11. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.
Wessels MR; Rubens CE; Benedí VJ; Kasper DL
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8983-7. PubMed ID: 2554337
[TBL] [Abstract][Full Text] [Related]
12. Virulence role of group B Streptococcus beta-hemolysin/cytolysin in a neonatal rabbit model of early-onset pulmonary infection.
Hensler ME; Liu GY; Sobczak S; Benirschke K; Nizet V; Heldt GP
J Infect Dis; 2005 Apr; 191(8):1287-91. PubMed ID: 15776375
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and molecular characterization of hyperpigmented group B Streptococci.
Lupo A; Ruppen C; Hemphill A; Spellerberg B; Sendi P
Int J Med Microbiol; 2014 Jul; 304(5-6):717-24. PubMed ID: 24933304
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy.
Doran KS; Nizet V
Mol Microbiol; 2004 Oct; 54(1):23-31. PubMed ID: 15458402
[TBL] [Abstract][Full Text] [Related]
15. Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8.
Doran KS; Chang JC; Benoit VM; Eckmann L; Nizet V
J Infect Dis; 2002 Jan; 185(2):196-203. PubMed ID: 11807693
[TBL] [Abstract][Full Text] [Related]
16. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.
Santi I; Scarselli M; Mariani M; Pezzicoli A; Masignani V; Taddei A; Grandi G; Telford JL; Soriani M
Mol Microbiol; 2007 Feb; 63(3):754-67. PubMed ID: 17212592
[TBL] [Abstract][Full Text] [Related]
17. Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis.
Jones AL; Knoll KM; Rubens CE
Mol Microbiol; 2000 Sep; 37(6):1444-55. PubMed ID: 10998175
[TBL] [Abstract][Full Text] [Related]
18. Isogenic group B streptococci devoid of capsular polysaccharide or beta-hemolysin: pulmonary hemodynamic and gas exchange effects during bacteremia in piglets.
Gibson RL; Redding GJ; Truog WE; Henderson WR; Rubens CE
Pediatr Res; 1989 Sep; 26(3):241-5. PubMed ID: 2685736
[TBL] [Abstract][Full Text] [Related]
19. The effects of interferon-gamma and transforming growth factor-beta on adherence and survival of group B Streptococcus type III strains in ECV304 cells.
Santos GS; Miyazaki NH; Mattos-Guaraldi AL; Nagao PE
Int J Mol Med; 2003 Mar; 11(3):401-6. PubMed ID: 12579348
[TBL] [Abstract][Full Text] [Related]
20. Intracellular viability in human non-polarized respiratory epithelial 16 HBE 14o- cells by group B Streptococcus serotype III clinical isolates presenting 162-kb and 183-kb virulence markers.
Sá de São José A; Miyazaki NH; Hirata R; Mattos-Guaraldi AL; Nagao PE
Int J Mol Med; 2006 Mar; 17(3):533-8. PubMed ID: 16465404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
